The estimated Net Worth of Marianna Mancini is at least $26.7 Milion dollars as of 29 July 2024. Marianna Mancini owns over 18,026 units of Viking Therapeutics Inc stock worth over $22,029,524 and over the last 4 years Marianna sold VKTX stock worth over $4,637,327.
Sign up
Marianna Mancini VKTX stock SEC Form 4 insiders trading
Marianna has made over 5 trades of the Viking Therapeutics Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Marianna sold 18,026 units of VKTX stock worth $1,029,825 on 29 July 2024.
The largest trade Marianna's ever made was exercising 281,425 units of Viking Therapeutics Inc stock on 1 May 2024 worth over $1,739,207. On average, Marianna trades about 41,464 units every 33 days since 2021. As of 29 July 2024 Marianna still owns at least 362,149 units of Viking Therapeutics Inc stock.
You can see the complete history of Marianna Mancini stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Marianna Mancini's mailing address?
Marianna's mailing address filed with the SEC is C/O VIKING THERAPEUTICS, INC., 9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA, 92121.
Insiders trading at Viking Therapeutics Inc
Over the last 10 years, insiders at Viking Therapeutics Inc have traded over $46,107,976 worth of Viking Therapeutics Inc stock and bought 199,715 units worth $855,627 . The most active insiders traders include Brian Lian, Charles A Jr Rowland oraz Marianna Mancini. On average, Viking Therapeutics Inc executives and independent directors trade stock every 75 days with the average trade being worth of $4,137,170. The most recent stock trade was executed by Brian Lian on 21 August 2024, trading 1,000 units of VKTX stock currently worth $7,770.
What does Viking Therapeutics Inc's logo look like?
Complete history of Marianna Mancini stock trades at Viking Therapeutics Inc
Viking Therapeutics Inc executives and stock owners
Viking Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Brian Lian,
President, Chief Executive Officer, Director -
Dr. Brian Lian Ph.D.,
Pres, CEO & Director -
Michael Morneau,
Vice President - Finance and Administration -
S. Kathy Rouan,
Independent Director -
Lawson Macartney,
Independent Chairman of the Board -
Charles Rowland,
Independent Director -
J. Matthew Singleton,
Independent Director -
Matthew Foehr,
Director -
Greg Zante,
Senior Vice President - Finance, IR Contact Officer -
Michael Morneau,
VP of Fin. & Admin. -
Marianne Mancini,
Chief Operating Officer -
Gregory S. Zante,
Chief Financial Officer -
Pharmaceuticals Inc Ligand,
10% owner -
Stephen W Webster,
Director -
Rochelle Hanley,
Chief Medical Officer -
Hiroko Masamune,
Chief Development Officer -
Marianna Mancini,
Chief Operating Officer -
Michael Dinerman,
Chief Operating Officer